Education and Training
Comparative Effectiveness of Particulate Versus Nonparticulate Steroid Injections for Musculoskeletal Conditions
This aims of this study are:
1. To determine if particulate or non-particulate corticosteroid injections are more effective at treating pain from musculoskeletal pathologies of the hip, glenohumeral joint, biceps tendon, or subacromial/subdeltoid bursa at 2 weeks, 3 months, or 6 months.
2. To determine if there is a significantly different side effect profile between particulate and non-particulate corticosteroids when used for hip, glenohumeral joint, biceps tendon, or subacromial/subdeltoid bursa injections.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- drug: Triamcinolone or Betamethasone
- drug: Dexamethasone
Eligibility
Inclusion Criteria:
- Age greater than or equal to 18
- Ability to provide informed consent
- Capable of complying with the outcome instruments used
- Capable of attending all planned follow up visits
- Patient is deemed appropriate for intra-articular hip, glenohumeral, peri-tendinous
biceps, or subdeltoid bursa corticosteroid injection by their treating physician for
the treatment of painful musculoskeletal condition
- Average pain of greater than or equal to 4/10 over the last 7 days
Exclusion Criteria:
- Unclear diagnosis
- Pregnancy
- Incarcerated patients
- Prior corticosteroid injection into the same anatomical site within the last 3 months
- Prior prosthetic surgery on the joint
- Any condition that increases injection risk such as bleeding tendencies, uncontrolled
diabetes, current active infection, or infection requiring antibiotics within the last
7 days
- Chronic opioid use to control pain
- Workers compensation and litigation
- BMI > 40
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Agnes Martinez Ith
650-721-7600
I'm interested